share_log

小林製薬---大幅続伸、紅こうじ問題収束と判断し国内証券では買い推奨に格上げ

Kobayashi Pharmaceutical Co., Ltd. - significant increase, upgrading to buy recommendation by domestic securities firms based on the assessment of resolving the red koji issue.

Fisco Japan ·  Nov 25, 2024 04:08

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
1
Comment Comment · Views 455

Recommended

Write a comment

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.